Chemical Structure (Complera 01)
Chemical structure of rilpivirine hydrochloride, one of the active ingredients in COMPLERA tablets.*
Complera Tablet, Film Coated
Product Images NDC 61958-1101
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Complera (NDC 61958-1101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Gilead Sciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Complera 02)
Chemical structure of the active ingredient rilpivirine hydrochloride, shown as a molecular formula diagram including aromatic rings and functional groups with an associated hydrochloride molecule.*
Chemical Structure (Complera 03)
Chemical structure of emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate, shown with molecular bonds and fragment details. The image includes a detailed depiction of the molecular components representing the active ingredients in COMPLERA tablets.*
Principal Display Panel (30 Tablet Bottle Label)
Label for COMPLERA tablets containing emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate at strengths of 200 mg, 25 mg, and 300 mg respectively. The film-coated oral tablets are packaged as 30 count and labeled by Gilead Sciences, Inc. The label includes storage instructions, pharmaceutical warnings, and manufacturing information noting production in Canada.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
